electroCore (ECOR) Expected to Post Quarterly Earnings on Wednesday

electroCore (NASDAQ:ECOR) is anticipated to release its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to post earnings of ($0.2720) per share and revenue of $10.93 million for the quarter. Individuals can find conference call details on the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Wednesday, November 4, 2026 at 4:30 PM ET.

electroCore (NASDAQ:ECOR) last announced its earnings results on Thursday, August 6th. The company reported ($0.33) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.42) by $0.09. The company had revenue of $9.45 million for the quarter, compared to the consensus estimate of $9.49 million. On average, analysts expect electroCore to post ($1.40) EPS for the current fiscal year and ($0.68) EPS for the next fiscal year.

electroCore Stock Down 4.8%

Shares of ECOR stock opened at $7.16 on Tuesday. electroCore has a 12 month low of $4.41 and a 12 month high of $12.70. The business’s 50 day moving average is $9.43 and its two-hundred day moving average is $7.74. The company has a market cap of $64.58 million, a PE ratio of -4.31 and a beta of 1.05.

Insider Activity

In related news, CFO Joshua S. Lev sold 3,000 shares of the business’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $9.36, for a total transaction of $28,080.00. Following the completion of the transaction, the chief financial officer owned 84,889 shares of the company’s stock, valued at approximately $794,561.04. The trade was a 3.41% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Thomas Errico bought 5,000 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The shares were acquired at an average price of $9.82 per share, with a total value of $49,100.00. Following the purchase, the director owned 363,904 shares in the company, valued at $3,573,537.28. This trade represents a 1.39% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders sold 20,000 shares of company stock worth $200,120. 7.80% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a research note on Monday, September 21st. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $18.00.

About electroCore

electroCore, Inc (NASDAQ: ECOR) is a commercial-stage medical device company focused on bioelectronic medicine and non-invasive vagus nerve stimulation (nVNS). Its technology is designed to stimulate the vagus nerve through the neck without requiring surgery or implanted components.

The company’s primary prescription product is gammaCore, a handheld nVNS device used for the acute treatment of pain associated with migraine and episodic cluster headaches in adults. electroCore also markets consumer-oriented products, including Truvaga, a handheld vagus nerve stimulation device positioned for general wellness applications.